🔎 Trials Near Me

Hjem › Major depresjon › Florida › Orlando

Kliniske studier for Major depresjon i Orlando, FL

19 studier for Major depresjon søker deltakere på steder i og rundt Orlando (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

RekruttererFase 3
  • Nova Psychiatry INC, Orlando
Alder 18 til 74 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

RekruttererFase 2
  • Clinical Neuroscience Solutions Inc. - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

RekruttererFase 3
  • Accel Research Sites - Maitland, Maitland · 6 mi unna
Alder 18 til 85 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

RekruttererFase 2
  • Seaport Investigator Site, Orlando
Alder 18 til 65 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

RekruttererFase 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Alder 18 til 65 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07284667

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

RekruttererFase 2
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
Alder 18 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

RekruttererFase 2
  • Draig Clinical Site, Orlando
Alder 18 til 75 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07300969

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

RekruttererFase 3
  • Clinical Neuroscience Solutions, LLC (Orlando), Orlando
  • Charter Research, Orlando
  • K2 Medical Research (Maitland), Maitland · 6 mi unna
Alder 18 til 74 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

RekruttererFase 3
  • Charter Research - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

RekruttererFase 3
  • Clinical Neuroscience Solutions, Inc., Orlando
Alder 18 til 74 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

RekruttererFase 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Alder 18 til 64 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06547489

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Orlando
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jul. 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi unna
  • Neurocrine Clinical Site, Maitland · 6 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 24. jul. 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

RekruttererFase 2
  • Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Alder 18 til 65 · Alle kjønn · Oppdatert 15. jun. 2026 · NCT07276997

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekruttererFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 29. okt. 2025 · NCT06786624

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

Rekrutterer
  • AdventHealth Neuroscience Institute, Orlando
Alder 60 og eldre · Alle kjønn · Oppdatert 22. okt. 2025 · NCT05877885

Study of ALTO-300 in MDD

RekruttererFase 2
  • Site 159, Clermont · 24 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 24. jul. 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

RekruttererFase 4
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
Alder 18 til 65 · Alle kjønn · Oppdatert 23. jan. 2025 · NCT06223880

Major depresjon-studier i andre byer

Andre studier i Orlando

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.